|
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis
|
5R01CA185251-04
|
$700,207
|
BEEBE, DAVID
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping
|
1R44CA210820-01A1
|
$989,401
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
|
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer
|
5R01CA186338-03
|
$342,938
|
LI, MIN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Zinc dysregulation as a druggable target in human skin photocarcinogenesis
|
1R03CA230949-01
|
$73,677
|
WONDRAK, GEORG
|
UNIVERSITY OF ARIZONA
|
|
Zinc Chemoprevention of Arsenic Co-Carcinogenesis
|
5R01CA182969-04
|
$314,363
|
HUDSON, LAURIE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Zinc Chemoprevention of Arsenic Co-Carcinogenesis
|
5R01CA182969-05
|
$314,363
|
HUDSON, LAURIE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Zileuton as a chemopreventive agent for chronic myeloid leukemia
|
5R01CA176179-04
|
$347,563
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Zileuton as a chemopreventive agent for chronic myeloid leukemia
|
5R01CA176179-05
|
$347,563
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$72,557
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Yoga Versus CBT-I for Insomnia in Cancer Survivors and Biobehavioral Mechanisms
|
5R01CA181064-04
|
$516,979
|
MUSTIAN, KAREN
|
UNIVERSITY OF ROCHESTER
|
|
Yoga Versus CBT-I for Insomnia in Cancer Survivors and Biobehavioral Mechanisms
|
5R01CA181064-05
|
$593,588
|
MUSTIAN, KAREN
|
UNIVERSITY OF ROCHESTER
|
|
Yoga Intervention for Family Caregivers of Patients with Brain Tumors
|
1R21CA218309-01A1
|
$174,000
|
MILBURY, KATHRIN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Yap and beta-catenin interactions in liver: Implications in Pathophysiology
|
5R01CA204586-02
|
$414,072
|
MONGA, SATDARSHAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Yap and beta-catenin interactions in liver: Implications in Pathophysiology
|
5R01CA204586-03
|
$416,268
|
MONGA, SATDARSHAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Yale SPORE in Skin Cancer
|
2P50CA121974-11A1
|
$2,500,000
|
BOSENBERG, MARCUS
|
YALE UNIVERSITY
|
|
Yale SPORE in Skin Cancer
|
3P50CA121974-10S1
|
$25,000
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
Yale SPORE in Skin Cancer
|
3P50CA121974-10S2
|
$709,079
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-03
|
$2,300,000
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-04
|
$2,507,598
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S1
|
$117,999
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S1
|
$117,999
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S2
|
$60,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S2
|
$60,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S3
|
$125,625
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S3
|
$125,625
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S4
|
$200,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S4
|
$200,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S5
|
$250,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S5
|
$250,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-38
|
$2,600,006
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-38
|
$2,600,006
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
3U10CA180826-03S1
|
$49,901
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-04
|
$951,500
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Xuan Wei lung cancer study
|
ZIA CP010121-02378
|
$11,686
|
Lan, Qing
|
DCEG (NCI)
|
|
XLF in double-strand break repair and chemo/radiosensitization
|
5R01CA166264-05
|
$307,700
|
POVIRK, LAWRENCE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Xeroderma Pigmentosum
|
ZIA CP010187-10777
|
$50,695
|
Achatz, Maria Isabel
|
DCEG (NCI)
|
|
Xenobiotic receptors
|
ZIA BC 005562
|
$741,267
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
|
ZIA BC 005708
|
$531,469
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
|
ZIA BC 005708
|
$741,267
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Workshop on Methods in Supportive Oncology Research
|
5R25CA181000-04
|
$309,257
|
TEMEL, JENNIFER
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Work Ability in Young Adult Surviviors (WAYS): A Quantitative Investigation
|
5R21CA191989-02
|
$168,563
|
DANHAUER, SUZANNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Womens Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S3
|
$175,562
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S1
|
$56,922
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S2
|
$165,708
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-05
|
$2,260,718
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
WNT4 IN ENDOCRINE RESPONSE AND RESISTANCE IN INVASIVE LOBULAR CARCINOMA
|
4R00CA193734-03
|
$249,000
|
SIKORA, MATTHEW
|
UNIVERSITY OF COLORADO DENVER
|
|
Wnt/?-catenin Signaling in Pancreatic Oncogenesis
|
1R01CA220236-01
|
$366,000
|
XIE, KEPING
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Wnt pathway dynamics in breast cancer metastasis
|
1K22CA207463-01
|
$188,042
|
ROARTY, KEVIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas
|
1K08CA218460-01
|
$106,531
|
MURGA-ZAMALLOA, CARLOS
|
UNIVERSITY OF MICHIGAN
|
|
Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas
|
5K08CA218460-02
|
$106,531
|
MURGA-ZAMALLOA, CARLOS
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|